JP2023517644A5 - - Google Patents
Info
- Publication number
- JP2023517644A5 JP2023517644A5 JP2022554681A JP2022554681A JP2023517644A5 JP 2023517644 A5 JP2023517644 A5 JP 2023517644A5 JP 2022554681 A JP2022554681 A JP 2022554681A JP 2022554681 A JP2022554681 A JP 2022554681A JP 2023517644 A5 JP2023517644 A5 JP 2023517644A5
- Authority
- JP
- Japan
- Prior art keywords
- lipid
- composition
- mol
- nucleic acid
- acid molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062987191P | 2020-03-09 | 2020-03-09 | |
| US62/987,191 | 2020-03-09 | ||
| US202063073900P | 2020-09-02 | 2020-09-02 | |
| US63/073,900 | 2020-09-02 | ||
| PCT/US2021/021572 WO2021183563A1 (en) | 2020-03-09 | 2021-03-09 | Coronavirus vaccine compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023517644A JP2023517644A (ja) | 2023-04-26 |
| JP2023517644A5 true JP2023517644A5 (cg-RX-API-DMAC7.html) | 2024-03-18 |
Family
ID=77671984
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022554681A Pending JP2023517644A (ja) | 2020-03-09 | 2021-03-09 | コロナウイルスワクチン組成物及び方法 |
| JP2022554368A Pending JP2023519173A (ja) | 2020-03-09 | 2021-03-09 | 免疫応答を誘導するための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022554368A Pending JP2023519173A (ja) | 2020-03-09 | 2021-03-09 | 免疫応答を誘導するための組成物及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (6) | US11759515B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4117725A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023517644A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2021236068A1 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3171219A1 (cg-RX-API-DMAC7.html) |
| TW (2) | TW202613312A (cg-RX-API-DMAC7.html) |
| WO (2) | WO2021183564A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10526284B2 (en) * | 2016-12-21 | 2020-01-07 | Arcturus Therapeutics, Inc. | Ionizable cationic lipid for RNA delivery |
| US10383952B2 (en) | 2016-12-21 | 2019-08-20 | Arcturus Therapeutics, Inc. | Ionizable cationic lipid for RNA delivery |
| US11679163B2 (en) | 2019-09-20 | 2023-06-20 | Hdt Bio Corp. | Compositions and methods for delivery of RNA |
| WO2021194672A1 (en) | 2020-03-23 | 2021-09-30 | Hdt Bio Corp. | Compositions and methods for delivery of rna |
| JP2023517644A (ja) | 2020-03-09 | 2023-04-26 | アークトゥラス・セラピューティクス・インコーポレイテッド | コロナウイルスワクチン組成物及び方法 |
| US12558415B2 (en) * | 2020-04-14 | 2026-02-24 | The Regents Of The University Of California | Broad-spectrum multi-antigen pan-coronavirus vaccine |
| CN118490818A (zh) | 2020-04-22 | 2024-08-16 | 生物技术欧洲股份公司 | 冠状病毒疫苗 |
| WO2022011332A2 (en) * | 2020-07-10 | 2022-01-13 | Engimata, Inc | Immunogenic composition forming a vaccine, and a method for its manufacture |
| US12178921B2 (en) | 2020-08-14 | 2024-12-31 | Arcturus Therapeutics, Inc. | Method of lyophilizing lipid nanoparticles |
| SE544840C2 (en) * | 2020-09-28 | 2022-12-13 | Stora Enso Oyj | Method for the preparation of a bio-based carbon foam |
| MX2023004371A (es) | 2020-10-14 | 2023-07-26 | George Mason Res Foundation Inc | Lípidos ionizables, y métodos de fabricación y uso de los mismos. |
| TW202237148A (zh) * | 2020-11-16 | 2022-10-01 | 德商拜恩迪克公司 | 包含rna之lnp組合物以及製備、儲存及使用彼之方法 |
| CN117098541A (zh) | 2020-11-25 | 2023-11-21 | 阿卡格拉医药公司 | 用于递送核酸的脂质纳米粒及相关使用方法 |
| US20220356212A1 (en) * | 2021-03-26 | 2022-11-10 | Nanogen Pharmaceutical Biotechnology JSC | Modified spike protein and method of treatment |
| EP4376883A4 (en) * | 2021-07-30 | 2025-07-16 | Arcturus Therapeutics Inc | RNA VACCINES |
| EP4763287A2 (en) | 2021-09-03 | 2026-06-24 | CureVac SE | Novel lipid nanoparticles for delivery of nucleic acids |
| AU2022347195A1 (en) * | 2021-09-20 | 2024-05-02 | Cyanvac Llc | Piv5-based coronavirus vaccines and methods of use thereof |
| JP2024535352A (ja) | 2021-09-22 | 2024-09-30 | エイチディーティー バイオ コーポレーション | Sars-cov-2 rnaワクチン組成物および使用方法 |
| CA3232658A1 (en) | 2021-09-22 | 2023-03-30 | Steven Gregory REED | Rna vaccines against infectious diseases |
| WO2023049636A2 (en) | 2021-09-22 | 2023-03-30 | Hdt Bio Corp. | Cancer therapy compositions and uses thereof |
| AU2022352486A1 (en) | 2021-09-22 | 2024-04-11 | Hdt Bio Corp. | Dried nanoparticle compositions |
| EP4413144A4 (en) * | 2021-10-07 | 2025-11-19 | Global Life Sciences Solutions Canada Ulc | RNA VACCINE LIPID NANOPARTICLES |
| WO2023079472A2 (en) * | 2021-11-03 | 2023-05-11 | Kashiv Biosciences, Llc | Multicistron expression vector for covid-19 vaccine |
| US20230159449A1 (en) * | 2021-11-03 | 2023-05-25 | Arcturus Therapeutics, Inc. | Lipid formulations containing nucleic acids and methods of treatment for cystic fibrosis |
| US11510975B1 (en) * | 2021-11-29 | 2022-11-29 | Replicate Bioscience, Inc. | Compositions and methods for inducing ESR1, PI3K, HER2, and HER3 immune responses |
| CA3238159A1 (en) * | 2021-11-29 | 2023-06-01 | Hong Jiang | Sars cov-2 vaccine, associated polynucleotides, and methods of use |
| US12186387B2 (en) | 2021-11-29 | 2025-01-07 | BioNTech SE | Coronavirus vaccine |
| US20250041238A1 (en) * | 2021-12-23 | 2025-02-06 | Etherna Immunotherapies Nv | METHOD FOR LAGRE-SCALE PRODUCTION OF LARGE-SIZE LNPs |
| EP4460509A1 (en) * | 2022-01-05 | 2024-11-13 | Helix Nanotechnologies Inc | Compositions comprising alpha-factor prepro sequence and uses thereof |
| EP4469091A1 (en) | 2022-01-28 | 2024-12-04 | CureVac SE | Nucleic acid encoded transcription factor inhibitors |
| JP2025507234A (ja) * | 2022-02-07 | 2025-03-18 | セキラス・インコーポレイテッド | 自己複製rna及びその使用配列表 本出願は、電子形態の配列表とともに出願される。配列表の全内容は、参照によって本明細書に組み込まれる。 |
| CN116768987A (zh) * | 2022-03-09 | 2023-09-19 | 中生复诺健生物科技(上海)有限公司 | 编码新型冠状病毒S蛋白的mRNA疫苗 |
| EP4511497A4 (en) * | 2022-04-19 | 2026-04-22 | Replicate Bioscience Inc | MODIFIED WESTERN EQUINE ENCEPHALITIS VIRUS AND ITS USES |
| CN114557971B (zh) * | 2022-04-25 | 2023-05-23 | 康希诺生物股份公司 | 一种核酸-脂质纳米颗粒的冷冻干燥保护剂及其制备方法和应用 |
| EP4522754A1 (en) * | 2022-05-12 | 2025-03-19 | Sunvax MRNA Therapeutics Inc. | Synthetic self-amplifying mrna molecules with secretion antigen and immunomodulator |
| WO2023221938A1 (zh) * | 2022-05-16 | 2023-11-23 | 上海行深生物科技有限公司 | 蛋白包裹自复制rna及其制备方法 |
| CA3248209A1 (en) | 2022-05-25 | 2023-11-30 | CureVac SE | Escherichia coli Antigenic Polypeptide-Based Nucleic Acid Vaccine (FIMH) |
| WO2023230587A2 (en) * | 2022-05-25 | 2023-11-30 | Akagera Medicines, Inc. | Lipid nanoparticles for delivery of nucleic acids and methods of use thereof |
| US11878055B1 (en) | 2022-06-26 | 2024-01-23 | BioNTech SE | Coronavirus vaccine |
| US20240100152A1 (en) * | 2022-09-06 | 2024-03-28 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Modified polynucleotides encoding the sars-cov-2 spike protein for safer designs of coronavirus vaccines |
| WO2024089229A1 (en) * | 2022-10-28 | 2024-05-02 | CureVac SE | Improved formulations comprising lipid-based carriers encapsulating rna |
| US12186388B2 (en) * | 2022-11-02 | 2025-01-07 | Centre For Virology, Vaccinology And Therapeutics Limited | Interferon-producing universal sarbecovirus vaccines, and uses thereof |
| TW202438672A (zh) * | 2023-01-31 | 2024-10-01 | 美商亞克圖羅斯醫療公司 | 四價流感疫苗之方法及組成物 |
| KR20250153298A (ko) | 2023-03-08 | 2025-10-24 | 큐어백 에스이 | 핵산 전달을 위한 신규의 지질 나노입자 제형 |
| WO2024230934A1 (en) | 2023-05-11 | 2024-11-14 | CureVac SE | Therapeutic nucleic acid for the treatment of ophthalmic diseases |
| EP4719352A1 (en) | 2023-05-31 | 2026-04-08 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| AU2024381228A1 (en) * | 2023-11-13 | 2026-05-28 | Ziphius Nv | MODIFIED ALPHAVIRAL nsP3 |
| WO2025103803A1 (en) | 2023-11-13 | 2025-05-22 | CureVac SE | Immunotherapy against neuronal and brain tumors |
| WO2025103414A1 (zh) * | 2023-11-14 | 2025-05-22 | 上海瑞宏迪医药有限公司 | 一种脂质纳米粒的制备方法和应用 |
| GB202400648D0 (en) * | 2024-01-17 | 2024-02-28 | Uea Enterprises Ltd | Protein replacement therapy |
| WO2025189168A1 (en) * | 2024-03-08 | 2025-09-12 | SunVax mRNA Therapeutics Inc. | Methods for cascade amplifications of therapeutic payloads (catp) & compositions for cancer immunotherapies and gene therapy |
| US20260002196A1 (en) * | 2024-07-01 | 2026-01-01 | New England Biolabs, Inc. | Programmable Cleavage of RNA |
| WO2026041140A1 (zh) * | 2024-08-23 | 2026-02-26 | 康希诺(上海)生物研发有限公司 | 一种自复制rna分子及其制备方法和应用 |
| JP7657411B1 (ja) * | 2025-01-23 | 2025-04-07 | 医療法人すぎやま内科 | 乳がん細胞の増殖抑制剤及び乳がん治療剤 |
Family Cites Families (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003023026A1 (en) | 2001-09-06 | 2003-03-20 | Alphavax, Inc. | Alphavirus replicon vector systems |
| EP1608762B1 (en) | 2003-03-20 | 2014-01-08 | Alphavax, Inc. | Improved alphavirus replicons and helper constructs |
| PT1751289E (pt) | 2004-05-18 | 2009-03-31 | Alphavax Inc | Vectores de alfavirais derivados da tc-83, partículas e métodos |
| US20090104226A1 (en) * | 2004-05-21 | 2009-04-23 | Novartis Vaccines And Diagnostics Inc. | Alphavirus Vectors for Respiratory Pathogen Vaccines |
| US7332322B2 (en) | 2004-09-14 | 2008-02-19 | Ilya Frolov | Venezuelan equine encephalitis virus replicons with adaptive mutations in the genome and uses thereof |
| WO2007098267A2 (en) * | 2006-02-27 | 2007-08-30 | The Board Of Regents Of The University Of Texas System | Pseudoinfectious flavivirus and uses thereof |
| EP2049665A2 (en) | 2006-07-28 | 2009-04-22 | Applera Corporation | Dinucleotide mrna cap analogs |
| WO2008119827A1 (en) * | 2007-04-02 | 2008-10-09 | Fit Biotech Oy | Transreplicase constructs |
| DK2947149T3 (en) | 2007-06-21 | 2018-06-06 | Alphavax Inc | ALPHAVIRUS REPLICATION PARTICLES FOR USE IN VACCINATION |
| WO2009058911A2 (en) | 2007-10-31 | 2009-05-07 | Applied Biosystems Inc. | Preparation and isolation of 5' capped mrna |
| WO2009079185A2 (en) * | 2007-11-26 | 2009-06-25 | Novartis Vaccines And Diagnostics, Inc. | Methods of generating alphavirus particles |
| EP3100718B1 (en) | 2008-01-02 | 2019-11-27 | Arbutus Biopharma Corporation | Improved compositions and methods for the delivery of nucleic acids |
| EP2279254B1 (en) | 2008-04-15 | 2017-07-05 | Protiva Biotherapeutics Inc. | Novel lipid formulations for nucleic acid delivery |
| CA2724570A1 (en) | 2008-05-23 | 2009-11-26 | Kaja Kiiver | Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant |
| AU2009303345B2 (en) | 2008-10-09 | 2015-08-20 | Arbutus Biopharma Corporation | Improved amino lipids and methods for the delivery of nucleic acids |
| WO2010048536A2 (en) | 2008-10-23 | 2010-04-29 | Alnylam Pharmaceuticals, Inc. | Processes for preparing lipids |
| EP3699172A3 (en) | 2008-11-10 | 2020-11-18 | Arbutus Biopharma Corporation | Novel lipids and compositions for the delivery of therapeutics |
| EP2391343B1 (en) | 2009-01-29 | 2017-03-01 | Arbutus Biopharma Corporation | Improved lipid formulation for the delivery of nucleic acids |
| CA3042927C (en) | 2009-05-05 | 2022-05-17 | Arbutus Biopharma Corporation | Lipid compositions for the delivery of therapeutic agents |
| KR20220038506A (ko) | 2009-06-10 | 2022-03-28 | 알닐람 파마슈티칼스 인코포레이티드 | 향상된 지질 조성물 |
| WO2011082388A2 (en) * | 2009-12-31 | 2011-07-07 | Medigen, Inc . | Infectious dna vaccines against chikungunya virus |
| EP4481047A3 (en) | 2010-06-03 | 2025-04-16 | Alnylam Pharmaceuticals, Inc. | Biodegradable lipids for the delivery of active agents |
| US10487332B2 (en) * | 2010-07-06 | 2019-11-26 | Glaxosmithkline Biologicals Sa | Immunisation of large mammals with low doses of RNA |
| FI4005592T3 (fi) | 2010-07-06 | 2023-01-13 | Virionin kaltaisia kuljetuspartikkeleita itsereplikoituville rna-molekyyleille | |
| CA2804591C (en) | 2010-07-06 | 2019-01-22 | Novartis Ag | Cationic oil-in-water emulsions |
| CN103153284B (zh) | 2010-07-06 | 2015-11-25 | 诺华股份有限公司 | 含有其pKa值有利于RNA递送的脂质的脂质体 |
| US9770463B2 (en) | 2010-07-06 | 2017-09-26 | Glaxosmithkline Biologicals Sa | Delivery of RNA to different cell types |
| JP5911870B2 (ja) | 2010-08-31 | 2016-04-27 | ノバルティス アーゲー | 免疫原をコードするrnaの送達のためのpeg化リポソーム |
| RS63890B1 (sr) | 2010-08-31 | 2023-02-28 | Glaxosmithkline Biologicals Sa | Mali lipozomi za isporuku rnk koja kodira imunogen |
| WO2012170431A2 (en) * | 2011-06-06 | 2012-12-13 | Bluebird Bio, Inc. | Improved geneswitch systems |
| US11058762B2 (en) | 2011-07-06 | 2021-07-13 | Glaxosmithkline Biologicals Sa | Immunogenic compositions and uses thereof |
| RU2014104090A (ru) | 2011-07-06 | 2015-08-20 | Новартис Аг | Липосомы с эффективным соотношением n:p для доставки молекул phk |
| US9636410B2 (en) | 2011-07-06 | 2017-05-02 | Glaxosmithkline Biologicals Sa | Cationic oil-in-water emulsions |
| JP2014522842A (ja) | 2011-07-06 | 2014-09-08 | ノバルティス アーゲー | 免疫原性組み合わせ組成物およびその使用 |
| PT2750707T (pt) | 2011-08-31 | 2019-01-23 | Glaxosmithkline Biologicals Sa | Lipossomas peguilados para distribuição de arn que codifica imunogénio |
| US8961995B2 (en) | 2012-09-20 | 2015-02-24 | Uab Research Foundation | Methods and compositions for alphavirus replicons |
| WO2014170493A2 (en) | 2013-04-19 | 2014-10-23 | Novartis Ag | Alphavirus vector |
| EP3052511A4 (en) | 2013-10-02 | 2017-05-31 | Moderna Therapeutics, Inc. | Polynucleotide molecules and uses thereof |
| EP3574923A1 (en) | 2013-10-22 | 2019-12-04 | Translate Bio, Inc. | Mrna therapy for phenylketonuria |
| US10842859B2 (en) | 2014-03-25 | 2020-11-24 | Yale University | Uses of parasite macrophage migration inhibitory factors |
| EP3061826A1 (en) | 2015-02-27 | 2016-08-31 | Novartis AG | Flavivirus replicons |
| DK3294326T3 (da) * | 2015-05-15 | 2021-05-31 | Curevac Ag | Prime-boost-regimer indbefattende indgivelse af mindst én mrna-konstruktion |
| DK4276189T3 (da) | 2015-09-21 | 2026-05-26 | Trilink Biotechnologies Llc | Initierende oligonukleotidprimere med kappe til syntesering af 5'-ende RNA'er med kappe |
| KR20180074699A (ko) * | 2015-11-09 | 2018-07-03 | 이뮨 디자인 코포레이션 | 이종 핵산을 발현하는 rna 레플리콘의 발현 및 투여를 위한 레트로바이러스 벡터 |
| WO2017162266A1 (en) * | 2016-03-21 | 2017-09-28 | Biontech Rna Pharmaceuticals Gmbh | Rna replicon for versatile and efficient gene expression |
| EP3471778A4 (en) | 2016-06-20 | 2020-02-19 | The Regents of The University of Michigan | COMPOSITIONS AND METHOD FOR DELIVERING BIOMACROMOLECOLIC ACTIVE SUBSTANCES |
| WO2018010815A1 (en) | 2016-07-15 | 2018-01-18 | Biontech Rna Pharmaceuticals Gmbh | Formulation for administration of rna |
| ES2993107T3 (en) | 2016-10-17 | 2024-12-23 | Janssen Pharmaceuticals Inc | Recombinant virus replicon systems and uses thereof |
| US10487105B2 (en) | 2016-10-19 | 2019-11-26 | Arcturus Therapeutics, Inc. | Trinucleotide MRNA cap analogs |
| KR20190093816A (ko) | 2016-10-26 | 2019-08-26 | 큐어백 아게 | 지질 나노입자 mRNA 백신 |
| RU2019119272A (ru) * | 2016-11-23 | 2020-12-24 | Гритстоун Онколоджи, Инк. | Вирусная доставка неоантигенов |
| JP7788787B2 (ja) | 2016-12-05 | 2025-12-19 | ヤンセン ファーマシューティカルズ,インコーポレーテッド | 遺伝子発現増強のための組成物および方法 |
| US10383952B2 (en) * | 2016-12-21 | 2019-08-20 | Arcturus Therapeutics, Inc. | Ionizable cationic lipid for RNA delivery |
| WO2018119163A1 (en) * | 2016-12-21 | 2018-06-28 | Payne Joseph E | Ionizable cationic lipid for rna delivery |
| US20190374650A1 (en) | 2017-02-22 | 2019-12-12 | The Regents Of The University Of Michigan | Compositions and methods for delivery of polymer/biomacromolecule conjugates |
| EP3589290A4 (en) | 2017-02-28 | 2020-12-30 | Arcturus Therapeutics, Inc. | Translatable molecules and synthesis thereof |
| KR102945203B1 (ko) | 2017-05-08 | 2026-03-31 | 시애틀 프로젝트 코포레이션 | 알파바이러스 신생항원 벡터 |
| KR102636537B1 (ko) * | 2017-05-31 | 2024-02-15 | 울트라제닉스 파마수티컬 인코포레이티드 | 글리코겐 축적 질환 유형 iii에 대한 치료제 |
| US11015204B2 (en) | 2017-05-31 | 2021-05-25 | Arcturus Therapeutics, Inc. | Synthesis and structure of high potency RNA therapeutics |
| WO2019023566A1 (en) * | 2017-07-28 | 2019-01-31 | Janssen Vaccines & Prevention B.V. | METHODS AND COMPOSITIONS FOR PROVIDING IMMUNIZATION AGAINST Heterologous ARNREP |
| EP3727444A1 (en) | 2017-12-18 | 2020-10-28 | Intervet International B.V. | Swine influenza a virus vaccine |
| KR20200111729A (ko) * | 2018-01-19 | 2020-09-29 | 얀센 파마슈티칼즈, 인코포레이티드 | 재조합 레플리콘 시스템을 이용한 면역 반응 유도 및 증진 |
| US12173032B2 (en) | 2018-07-13 | 2024-12-24 | The Trustees Of Indiana University | Recombinant rotavirus expression system and recombinant rotaviruses |
| AU2019321186B2 (en) | 2018-08-17 | 2024-05-23 | Glaxosmithkline Biologicals Sa | Immunogenic compositions and uses thereof |
| WO2020146700A1 (en) | 2019-01-10 | 2020-07-16 | Massachusetts Institute Of Technology | Lipid nanoparticles |
| EP3942050A4 (en) | 2019-03-19 | 2023-02-22 | Arcturus Therapeutics, Inc. | PROCEDURE FOR THE PRODUCTION OF LIPID-COATED RNA NANOPARTICLES |
| GB201908729D0 (en) | 2019-06-18 | 2019-07-31 | Imp College Innovations Ltd | RNA construct |
| EP3986452A1 (en) | 2019-06-18 | 2022-04-27 | CureVac AG | Rotavirus mrna vaccine |
| EP3986458A1 (en) | 2019-06-20 | 2022-04-27 | Janssen Sciences Ireland Unlimited Company | Self-replicating rna molecules for hepatitis b virus (hbv) vaccines and uses thereof |
| HRP20241379T1 (hr) | 2019-09-30 | 2024-12-20 | Gilead Sciences, Inc. | Cjepiva za hbv i postupci za liječenje hbv |
| WO2021067598A1 (en) * | 2019-10-04 | 2021-04-08 | Ultragenyx Pharmaceutical Inc. | Methods for improved therapeutic use of recombinant aav |
| US12194089B2 (en) * | 2020-02-04 | 2025-01-14 | CureVac SE | Coronavirus vaccine |
| EP4103228A1 (en) * | 2020-02-13 | 2022-12-21 | Institut Pasteur | Nucleic acid vaccine against the sars-cov-2 coronavirus |
| EP4114470A4 (en) * | 2020-03-03 | 2024-04-17 | Arcturus Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR TREATING ORNITHINE TRANSCARBAMYLASE DEFICIENCY |
| JP2023517644A (ja) | 2020-03-09 | 2023-04-26 | アークトゥラス・セラピューティクス・インコーポレイテッド | コロナウイルスワクチン組成物及び方法 |
| EP4376883A4 (en) | 2021-07-30 | 2025-07-16 | Arcturus Therapeutics Inc | RNA VACCINES |
-
2021
- 2021-03-09 JP JP2022554681A patent/JP2023517644A/ja active Pending
- 2021-03-09 US US17/196,890 patent/US11759515B2/en active Active
- 2021-03-09 AU AU2021236068A patent/AU2021236068A1/en active Pending
- 2021-03-09 EP EP21767978.6A patent/EP4117725A4/en active Pending
- 2021-03-09 US US17/196,889 patent/US11744887B2/en active Active
- 2021-03-09 AU AU2021233816A patent/AU2021233816A1/en active Pending
- 2021-03-09 TW TW114121801A patent/TW202613312A/zh unknown
- 2021-03-09 TW TW110108383A patent/TW202200605A/zh unknown
- 2021-03-09 WO PCT/US2021/021573 patent/WO2021183564A1/en not_active Ceased
- 2021-03-09 JP JP2022554368A patent/JP2023519173A/ja active Pending
- 2021-03-09 EP EP21768525.4A patent/EP4117720A4/en active Pending
- 2021-03-09 CA CA3171219A patent/CA3171219A1/en active Pending
- 2021-03-09 WO PCT/US2021/021572 patent/WO2021183563A1/en not_active Ceased
- 2021-03-09 CA CA3171231A patent/CA3171231A1/en active Pending
-
2023
- 2023-06-30 US US18/345,893 patent/US12220455B2/en active Active
- 2023-07-12 US US18/351,392 patent/US12390524B2/en active Active
-
2024
- 2024-12-04 US US18/969,110 patent/US20250161434A1/en active Pending
-
2025
- 2025-07-15 US US19/270,365 patent/US20260069677A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12220455B2 (en) | Coronavirus vaccine compositions and methods | |
| KR102956148B1 (ko) | 지질-캡슐화된 rna 나노입자 제조 방법 | |
| JP2024529975A5 (cg-RX-API-DMAC7.html) | ||
| JP7774615B2 (ja) | 大型rnaの脂質ナノ粒子封入 | |
| US12533318B2 (en) | Jet mixing lipid nanoparticle manufacturing process | |
| JP2024529975A (ja) | Rnaワクチン | |
| JP2024542099A5 (cg-RX-API-DMAC7.html) | ||
| JP2025503423A (ja) | ポリヌクレオチド組成物およびその使用 | |
| JP2025527583A (ja) | 脂質ナノ粒子の組成物 | |
| JP2024513048A (ja) | Rnaの送達のための組成物及び方法 | |
| EP4271389A1 (en) | Compositions and methods for delivery of rna | |
| TW202438672A (zh) | 四價流感疫苗之方法及組成物 | |
| WO2024064886A1 (en) | Using n-terminal degrons to enhance rna t cell vaccine immunogenicity | |
| WO2026029847A1 (en) | Methods and compositions for pandemic influenza vaccine | |
| HK40110708A (en) | Rna vaccines | |
| HK40113162A (en) | Polynucleotide compositions and uses thereof | |
| BR112023004313B1 (pt) | Métodos para produção nanopartículas de rna encapsuladas em lipídeo |